Research Article
BibTex RIS Cite

Meme Kanseri Hücre Dizisi Üzerinde (MCF-7) Oğulotu (Melissa Officinalis) Bitki Ekstresinin Antiproliferatif, Apoptotik ve Antioksidan Etkilerinin Araştırılması

Year 2023, Volume: 7 Issue: 1, 136 - 144, 31.01.2023
https://doi.org/10.46237/amusbfd.1194803

Abstract

Amaç: Meme kanseri, dünyada ve ülkemizde kadınlarda en sık teşhis edilen kanser türlerinden biridir. Dünya geneline bakıldığında ölüm sebepleri arasında kadınlarda ikinci sırada yer aldığı bilinmektedir. Bu çalışmanın amacı, Melissa officinalis ekstresinin meme kanseri hücre dizisinde (MCF-7) antiproliferatif, apoptotik ve antioksidan etkilerinin belirlenmesidir.
Yöntem: Araştırmada oğulotu bitki ekstresinin farklı konsantrasyonları (1 µg/mL, 10 µg/mL, 100 µg/mL ve 1000 µg/mL) MCF-7 hücre dizisi üzerine uygulanmıştır. Sitotoksik aktiviteleri 24 saatte MTT yöntemi, apoptotik aktiviteleri ise muse anneksin V yöntemi kullanılarak belirlenmiştir. Biyokimyasal parametrelerin belirlenmesinde 1 µg/mL, 10 µg/mL, 100 µg/mL ve 1000 µg/mL dozlarda hücrelere uygulama yapılmış ve sonra hücre lizatları elde edilmiştir. Hazırlanan numuneler ile ilk olarak hücrenin protein düzeyi hesaplanmıştır. Ardından TOS, TAS, OSİ, SOD, GPx aktivite tayini, MDA ve NO analizleri yapılmıştır.
Bulgular: Sonuçlar değerlendirildiğinde, araştırmamızda doz ve zamana bağlı olarak Melissa officinalis ekstresinin MCF-7 hücre proliferasyonunu azalttığı belirlenmiştir. Aynı zamanda elde ettiğimiz apoptoz artışı da bu proliferasyon inhibisyonunu açıklamaktadır. Araştırma çerçevesinde ortaya çıkan antioksidan sonuçları da proliferasyonun inhibisyonunu ve aynı zamanda apoptozun artışını desteklemektedir.
Sonuç: İstatistiksel olarak tüm veriler yorumlandığında Melissa officinalis ekstresinin, MCF-7 hücrelerinde moleküler antikanserojenik mekanizmaları, tekli ya da kemoterapötik ajanlarla kombine çalışılarak, meme kanseri tedavisi için yeni kemoterapötik ve kemopreventif ajanların gelişimine önemli katkı sağlayacağı mevcut araştırma ile belirlenmiştir.

Supporting Institution

Adnan Menderes Üniversitesi Bilimsel Araştırma Projeleri Koordinatörlüğü

Project Number

TPF-19040

References

  • 1. Lord, C. J., & Ashworth, A. (2012). The DNA damage response and cancer therapy. Nature, 481(7381), 287-294Heale, R. (2019). Maternity and postpartum care: perspectives. Evidence-Based Nursing, 22(2), 42-43.
  • 2. Ganesh, K., & Massagué, J. (2021). Targeting metastatic cancer. Nature medicine, 27(1), 34-44.
  • 3. Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., et al. (2011). Invasive breast cancer. Journal of the National Comprehensive Cancer Network, 9(2), 136-222.
  • 4. Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kümmel, S., ... & O’Shaughnessy, J. (2022). Event-free survival with pembrolizumab in early triple-negative breast cancer. New England Journal of Medicine, 386(6), 556-567.
  • 5. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast, 66, 15-23.
  • 6. Chu, E., & Sartorelli, A. C. (2018). Cancer chemotherapy. Katzung B. G. (Ed.), Basic and Clinical Pharmacology, (ss. 948-976). Lange.
  • 7. Kaufmann, S. H., & Earnshaw, W. C. (2000). Induction of apoptosis by cancer chemotherapy. Experimental cell research, 256(1), 42-49.
  • 8. Shen, X. G., Wang, C., Li, Y., Wang, L., Zhou, B., Xu, B., et al. (2010). Downregulation of caspase‐9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome. Colorectal Disease, 12(12), 1213-1218.
  • 9. Wang, Y., Shi, L. Y., Qi, W. H., Yang, J., & Qi, Y. (2020). Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway. Archives of Medical Science, 16(2), 428-435.
  • 10. Rath, M., Panda, S. S., & Dhal, N. K. (2014). Synthesis of silver nano particles from plant extract and its application in cancer treatment: a review. Int J Plant Anim Environ Sci, 4(3), 137-45.
  • 11. Shakeri, A., Sahebkar, A., & Javadi, B. (2016). Melissa officinalis L.–A review of its traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology, 188, 204-228.
  • 12. Miraj, S., Rafieian-Kopaei, & Kiani, S. (2017). Melissa officinalis L: A Review study with an antioxidant prospective. Journal of evidence-based complementary & alternative medicine, 22(3), 385-394.
  • 13. Sun, J., Chen, Y., Li, M., & Ge, Z. (1998). Role of antioxidant enzymes on ionizing radiation resistance. Free Radical Biology and Medicine, 24(4), 586-593.
  • 14. Paglia, D. E., & Valentine, W. N. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of laboratory and clinical medicine, 70(1), 158-169.
  • 15. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95(2), 351-358.
  • 16. Navarro-Gonzalvez, J. A., García-Benayas, C., & Arenas, J. (1998). Semiautomated measurement of nitrate in biological fluids. Clinical chemistry, 44(3), 679-681.
  • 17. DeVita Jr, V. T., & Chu, E. (2008). A history of cancer chemotherapy. Cancer research, 68(21), 8643-8653.
  • 18. Aitkin, R. J., & Roman, S. D. (2008). Antioxidant systems and oxidative stress in the testis. Oxid Med Cell Longev, 1, 15-24.
  • 19. Seifried, H. E., McDonald, S. S., Anderson, D. E., Greenwald, P., & Milner, J. A. (2003). The antioxidant conundrum in cancer. Cancer research, 63(15), 4295-4298.
  • 20. Ramasamy, S. P., Rajendran, A., Pallikondaperumal, M., Sundararajan, P., Husain, F. M., Khan, A., et al. (2022). Broad-Spectrum antimicrobial, antioxidant, and anticancer studies of leaf extract of simarouba glauca DC in vitro. Antibiotics, 11(1), 59.
  • 21. Qanash, H., Yahya, R., Bakri, M. M., Bazaid, A. S., Qanash, S., Shater, A. F., et al. (2022). Anticancer, antioxidant, antiviral and antimicrobial activities of Kei Apple (Dovyalis caffra) fruit. Scientific Reports, 12(1), 1-15.
  • 22. Sophia, A., Faiyazuddin, M., Alam, P., Hussain, M. T., & Shakeel, F. (2022). GC–MS characterization and evaluation of antimicrobial, anticancer and wound healing efficiency of combined ethanolic extract of Tridax procumbens and Acalypha indica. Journal of Molecular Structure, 1250, 131678.
  • 23. Saraydin, S. U., Tuncer, E., Tepe, B., Karadayi, S., Ozer, H., Sen, M., et al. (2012). Antitumoral effects of Melissa officinalis on breast cancer in vitro and in vivo. Asian Pacific Journal of Cancer Prevention, 13(6), 2765- 2770.
  • 24. Weidner, C., Rousseau, M., Plauth, A., Wowro, S. J., Fischer, C., Abdel-Aziz, H., et al. (2015). Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species. Phytomedicine, 22(2), 262-270.
  • 25. Gałasiński, W., Chlabicz, J., Paszkiewicz-Gadek, A., Marcinkiewicz, C., & Gindzieński, A. (1996). The substances of plant origin that inhibit protein biosynthesis. Acta poloniae pharmaceutica, 53(5), 311-318.

Investigation of Antiproliferative, Apoptotic and Antioxidant Effects of Lemon Balm (Melissa Officinalis) Plant Extract on Breast Cancer Cell Line (MCF-7)

Year 2023, Volume: 7 Issue: 1, 136 - 144, 31.01.2023
https://doi.org/10.46237/amusbfd.1194803

Abstract

Objective: Breast cancer is one of the most frequently diagnosed cancer types in women in the world and in our country. It is known that it is the second leading cause of death in women worldwide. The aim of this study is to determine the antiproliferative, apoptotic and antioxidant effects of Melissa officinalis extract on breast cancer cell line (MCF-7).
Methods: In the study, different concentrations of Melissa officinalis extract (1 µg/mL, 10 µg/mL, 100 µg/mL and 1000 µg/mL) were applied to the MCF-7 cell line. Cytotoxic activities were determined using the MTT method at 24 hours, and apoptotic activities were determined using the muse annexin V method. To determine the biochemical parameters, 1 µg/mL, 10 µg/mL, 100 µg/mL and 1000 µg/mL doses were applied to the cells and then cell lysates were obtained. Firstly, the protein level of the cell was calculated with the prepared samples. Then, TOS, TAS, OSI, SOD, GPx activity determination, MDA and NO analyzes were investigated.
Results: When the results were evaluated, it was determined in our study that Melissa officinalis extract decreased MCF-7 cell proliferation depending on dose and time. At the same time, the increase in apoptosis we obtained explains this proliferation inhibition. The antioxidant results that emerged within the framework of the research also support the inhibition of proliferation and also the increase of apoptosis.
Conclusion: When all the statistical data are interpreted, it has been determined by the current research that the molecular anticarcinogenic mechanisms of Melissa officinalis extract in MCF-7 cells will contribute to the development of new chemotherapeutic and chemopreventive agents for breast cancer treatment by working alone or in combination with chemotherapeutic agents.

Project Number

TPF-19040

References

  • 1. Lord, C. J., & Ashworth, A. (2012). The DNA damage response and cancer therapy. Nature, 481(7381), 287-294Heale, R. (2019). Maternity and postpartum care: perspectives. Evidence-Based Nursing, 22(2), 42-43.
  • 2. Ganesh, K., & Massagué, J. (2021). Targeting metastatic cancer. Nature medicine, 27(1), 34-44.
  • 3. Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., et al. (2011). Invasive breast cancer. Journal of the National Comprehensive Cancer Network, 9(2), 136-222.
  • 4. Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kümmel, S., ... & O’Shaughnessy, J. (2022). Event-free survival with pembrolizumab in early triple-negative breast cancer. New England Journal of Medicine, 386(6), 556-567.
  • 5. Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., et al. (2022). Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast, 66, 15-23.
  • 6. Chu, E., & Sartorelli, A. C. (2018). Cancer chemotherapy. Katzung B. G. (Ed.), Basic and Clinical Pharmacology, (ss. 948-976). Lange.
  • 7. Kaufmann, S. H., & Earnshaw, W. C. (2000). Induction of apoptosis by cancer chemotherapy. Experimental cell research, 256(1), 42-49.
  • 8. Shen, X. G., Wang, C., Li, Y., Wang, L., Zhou, B., Xu, B., et al. (2010). Downregulation of caspase‐9 is a frequent event in patients with stage II colorectal cancer and correlates with poor clinical outcome. Colorectal Disease, 12(12), 1213-1218.
  • 9. Wang, Y., Shi, L. Y., Qi, W. H., Yang, J., & Qi, Y. (2020). Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway. Archives of Medical Science, 16(2), 428-435.
  • 10. Rath, M., Panda, S. S., & Dhal, N. K. (2014). Synthesis of silver nano particles from plant extract and its application in cancer treatment: a review. Int J Plant Anim Environ Sci, 4(3), 137-45.
  • 11. Shakeri, A., Sahebkar, A., & Javadi, B. (2016). Melissa officinalis L.–A review of its traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology, 188, 204-228.
  • 12. Miraj, S., Rafieian-Kopaei, & Kiani, S. (2017). Melissa officinalis L: A Review study with an antioxidant prospective. Journal of evidence-based complementary & alternative medicine, 22(3), 385-394.
  • 13. Sun, J., Chen, Y., Li, M., & Ge, Z. (1998). Role of antioxidant enzymes on ionizing radiation resistance. Free Radical Biology and Medicine, 24(4), 586-593.
  • 14. Paglia, D. E., & Valentine, W. N. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of laboratory and clinical medicine, 70(1), 158-169.
  • 15. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95(2), 351-358.
  • 16. Navarro-Gonzalvez, J. A., García-Benayas, C., & Arenas, J. (1998). Semiautomated measurement of nitrate in biological fluids. Clinical chemistry, 44(3), 679-681.
  • 17. DeVita Jr, V. T., & Chu, E. (2008). A history of cancer chemotherapy. Cancer research, 68(21), 8643-8653.
  • 18. Aitkin, R. J., & Roman, S. D. (2008). Antioxidant systems and oxidative stress in the testis. Oxid Med Cell Longev, 1, 15-24.
  • 19. Seifried, H. E., McDonald, S. S., Anderson, D. E., Greenwald, P., & Milner, J. A. (2003). The antioxidant conundrum in cancer. Cancer research, 63(15), 4295-4298.
  • 20. Ramasamy, S. P., Rajendran, A., Pallikondaperumal, M., Sundararajan, P., Husain, F. M., Khan, A., et al. (2022). Broad-Spectrum antimicrobial, antioxidant, and anticancer studies of leaf extract of simarouba glauca DC in vitro. Antibiotics, 11(1), 59.
  • 21. Qanash, H., Yahya, R., Bakri, M. M., Bazaid, A. S., Qanash, S., Shater, A. F., et al. (2022). Anticancer, antioxidant, antiviral and antimicrobial activities of Kei Apple (Dovyalis caffra) fruit. Scientific Reports, 12(1), 1-15.
  • 22. Sophia, A., Faiyazuddin, M., Alam, P., Hussain, M. T., & Shakeel, F. (2022). GC–MS characterization and evaluation of antimicrobial, anticancer and wound healing efficiency of combined ethanolic extract of Tridax procumbens and Acalypha indica. Journal of Molecular Structure, 1250, 131678.
  • 23. Saraydin, S. U., Tuncer, E., Tepe, B., Karadayi, S., Ozer, H., Sen, M., et al. (2012). Antitumoral effects of Melissa officinalis on breast cancer in vitro and in vivo. Asian Pacific Journal of Cancer Prevention, 13(6), 2765- 2770.
  • 24. Weidner, C., Rousseau, M., Plauth, A., Wowro, S. J., Fischer, C., Abdel-Aziz, H., et al. (2015). Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species. Phytomedicine, 22(2), 262-270.
  • 25. Gałasiński, W., Chlabicz, J., Paszkiewicz-Gadek, A., Marcinkiewicz, C., & Gindzieński, A. (1996). The substances of plant origin that inhibit protein biosynthesis. Acta poloniae pharmaceutica, 53(5), 311-318.
There are 25 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Research Articles
Authors

Serdal Öğüt 0000-0001-8863-7249

Ömer Erdoğan 0000-0002-8327-7077

Aslıhan Büyüköztürk Karul 0000-0002-3738-2888

Project Number TPF-19040
Publication Date January 31, 2023
Published in Issue Year 2023 Volume: 7 Issue: 1

Cite

APA Öğüt, S., Erdoğan, Ö., & Büyüköztürk Karul, A. (2023). Meme Kanseri Hücre Dizisi Üzerinde (MCF-7) Oğulotu (Melissa Officinalis) Bitki Ekstresinin Antiproliferatif, Apoptotik ve Antioksidan Etkilerinin Araştırılması. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 7(1), 136-144. https://doi.org/10.46237/amusbfd.1194803